Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graziella Callari

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|March 11, 2014
Analysis of thiamine transporter genes in sporadic beriberiValentina Bravatà, Luigi Minafra, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2006
Age at menopause predicts age at onset of Parkinson's diseasePaolo Ragonese, Marco D'Amelio, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2007
Height as a potential indicator of early life events predicting Parkinson's disease: a case-control studyPaolo Ragonese, Marco D'Amelio, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Tumor diagnosis preceding Parkinson's disease: a case-control studyMarco D'Amelio, Paolo Ragonese, Letterio Morgante, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2021
Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom managementCinzia Cordioli, Graziella Callari, Roberta Fantozzi, et al.
Frontiers in Neurology|March 12, 2020
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter ExperienceAurora Zanghì, Emanuele D'Amico, Graziella Callari, et al.
Parkinsonism & Related Disorders|April 10, 2009
Diabetes preceding Parkinson's disease onset. A case-control studyMarco D'Amelio, Paolo Ragonese, Graziella Callari, et al.
Current Neuropharmacology|October 25, 2023
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian ExperienceAurora Zanghì, Diana Ferraro, Graziella Callari, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 29, 2022
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 PandemicAurora Zanghì, Carlo Avolio, Elisabetta Signoriello, et al.
Therapeutic Advances in Neurological Disorders|September 14, 2018
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experienceEmanuele D'Amico, Aurora Zanghì, Graziella Callari, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nutrition (Burbank, Los Angeles County, Calif.)|March 11, 2014
Analysis of thiamine transporter genes in sporadic beriberiValentina Bravatà, Luigi Minafra, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2006
Age at menopause predicts age at onset of Parkinson's diseasePaolo Ragonese, Marco D'Amelio, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2007
Height as a potential indicator of early life events predicting Parkinson's disease: a case-control studyPaolo Ragonese, Marco D'Amelio, Graziella Callari, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Tumor diagnosis preceding Parkinson's disease: a case-control studyMarco D'Amelio, Paolo Ragonese, Letterio Morgante, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2021
Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom managementCinzia Cordioli, Graziella Callari, Roberta Fantozzi, et al.
Frontiers in Neurology|March 12, 2020
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter ExperienceAurora Zanghì, Emanuele D'Amico, Graziella Callari, et al.
Parkinsonism & Related Disorders|April 10, 2009
Diabetes preceding Parkinson's disease onset. A case-control studyMarco D'Amelio, Paolo Ragonese, Graziella Callari, et al.
Current Neuropharmacology|October 25, 2023
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian ExperienceAurora Zanghì, Diana Ferraro, Graziella Callari, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 29, 2022
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 PandemicAurora Zanghì, Carlo Avolio, Elisabetta Signoriello, et al.
Therapeutic Advances in Neurological Disorders|September 14, 2018
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experienceEmanuele D'Amico, Aurora Zanghì, Graziella Callari, et al.
Pageof 2